{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:46:58Z","timestamp":1793144818626,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T00:00:00Z","timestamp":1604448000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T00:00:00Z","timestamp":1604448000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s10875-020-00901-8","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:08:53Z","timestamp":1604534933000},"page":"185-193","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Infections in Patients with Chronic Granulomatous Disease Treated with Tumor Necrosis Factor Alpha Blockers for Inflammatory Complications"],"prefix":"10.1007","volume":"41","author":[{"given":"Anne","family":"Conrad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Neven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nizar","family":"Mahlaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Sokol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank M.","family":"Ruemmele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Rouzaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despina","family":"Moshous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lortholary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Blanche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Lanternier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,4]]},"reference":[{"key":"901_CR1","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/00005792-200005000-00003","volume":"79","author":"JA Winkelstein","year":"2000","unstructured":"Winkelstein JA, Marino MC, Johnston RB, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore). 2000;79:155\u201369.","journal-title":"Medicine (Baltimore)"},{"key":"901_CR2","doi-asserted-by":"publisher","first-page":"S123","DOI":"10.1016\/j.bbmt.2010.09.008","volume":"17","author":"BH Segal","year":"2011","unstructured":"Segal BH, Veys P, Malech H, Cowan MJ. Chronic granulomatous disease: lessons from a rare disorder. Biol Blood Marrow Transplant. 2011;17:S123\u201331.","journal-title":"Biol Blood Marrow Transplant"},{"key":"901_CR3","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/ng0295-202","volume":"9","author":"JD Pollock","year":"1995","unstructured":"Pollock JD, Williams DA, Gifford MA, et al. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat Genet. 1995;9:202\u20139.","journal-title":"Nat Genet"},{"key":"901_CR4","doi-asserted-by":"publisher","first-page":"636","DOI":"10.4049\/jimmunol.172.1.636","volume":"172","author":"SD Kobayashi","year":"2004","unstructured":"Kobayashi SD, Voyich JM, Braughton KR, Whitney AR, Nauseef WM, Malech HL, et al. Gene expression profiling provides insight into the pathophysiology of chronic granulomatous disease. J Immunol. 2004;172:636\u201343.","journal-title":"J Immunol"},{"key":"901_CR5","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1093\/cid\/ciu1154","volume":"60","author":"BE Marciano","year":"2015","unstructured":"Marciano BE, Spalding C, Fitzgerald A, Mann D, Brown T, Osgood S, et al. Common severe infections in chronic granulomatous disease. Clin Infect Dis. 2015;60:1176\u201383.","journal-title":"Clin Infect Dis"},{"key":"901_CR6","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.jaci.2014.04.014","volume":"134","author":"A Magnani","year":"2014","unstructured":"Magnani A, Brosselin P, Beaut\u00e9 J, et al. Inflammatory manifestations in a single-center cohort of patients with chronic granulomatous disease. J Allergy Clin Immunol. 2014;134:655\u2013662.e8.","journal-title":"J Allergy Clin Immunol"},{"key":"901_CR7","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1093\/infdis\/162.3.723","volume":"162","author":"DM Margolis","year":"1990","unstructured":"Margolis DM, Melnick DA, Alling DW, Gallin JI. Trimethoprim-sulfamethoxazole prophylaxis in the management of chronic granulomatous disease. J Infect Dis. 1990;162:723\u20136.","journal-title":"J Infect Dis"},{"key":"901_CR8","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1056\/NEJMoa021931","volume":"348","author":"JI Gallin","year":"2003","unstructured":"Gallin JI, Alling DW, Malech HL, Wesley R, Koziol D, Marciano B, et al. Itraconazole to prevent fungal infections in chronic granulomatous disease. N Engl J Med. 2003;348:2416\u201322.","journal-title":"N Engl J Med"},{"key":"901_CR9","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1093\/cid\/ciu646","volume":"59","author":"C Aguilar","year":"2014","unstructured":"Aguilar C, Malphettes M, Donadieu J, Chandesris O, Coignard-Biehler H, Catherinot E, et al. Prevention of infections during primary immunodeficiency. Clin Infect Dis. 2014;59:1462\u201370.","journal-title":"Clin Infect Dis"},{"key":"901_CR10","doi-asserted-by":"crossref","unstructured":"Magnani A, Mahlaoui N. Managing inflammatory manifestations in patients with chronic granulomatous disease. Paediatr Drugs. 2016;18:335\u201345.","DOI":"10.1007\/s40272-016-0182-4"},{"key":"901_CR11","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1542\/peds.114.2.462","volume":"114","author":"BE Marciano","year":"2004","unstructured":"Marciano BE, Rosenzweig SD, Kleiner DE, Anderson VL, Darnell DN, Anaya-O'Brien S, et al. Gastrointestinal involvement in chronic granulomatous disease. Pediatrics. 2004;114:462\u20138.","journal-title":"Pediatrics"},{"key":"901_CR12","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1183\/09031936.00118414","volume":"45","author":"H Salvator","year":"2015","unstructured":"Salvator H, Mahlaoui N, Catherinot E, Rivaud E, Pilmis B, Borie R, et al. Pulmonary manifestations in adult patients with chronic granulomatous disease. Eur Respir J. 2015;45:1613\u201323.","journal-title":"Eur Respir J"},{"key":"901_CR13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/ajg.2008.72","volume":"104","author":"DJB Marks","year":"2009","unstructured":"Marks DJB, Miyagi K, Rahman FZ, Novelli M, Bloom SL, Segal AW. Inflammatory bowel disease in CGD reproduces the clinicopathological features of Crohn\u2019s disease. Am J Gastroenterol. 2009;104:117\u201324.","journal-title":"Am J Gastroenterol"},{"key":"901_CR14","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.cgh.2015.10.030","volume":"14","author":"SK Khangura","year":"2016","unstructured":"Khangura SK, Kamal N, Ho N, et al. Gastrointestinal features of chronic granulomatous disease found during endoscopy. Clin Gastroenterol Hepatol. 2016;14:395\u2013402.e5.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"901_CR15","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/cid\/ciw837","volume":"64","author":"B Dunogu\u00e9","year":"2017","unstructured":"Dunogu\u00e9 B, Pilmis B, Mahlaoui N, Elie C, Coignard-Biehler H, Amazzough K, et al. Chronic granulomatous disease in patients reaching adulthood: a nationwide study in France. Clin Infect Dis. 2017;64:767\u201375.","journal-title":"Clin Infect Dis"},{"key":"901_CR16","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.jaci.2013.04.059","volume":"132","author":"N Noel","year":"2013","unstructured":"Noel N, Mahlaoui N, Blanche S, et al. Efficacy and safety of thalidomide in patients with inflammatory manifestations of chronic granulomatous disease: a retrospective case series. J Allergy Clin Immunol. 2013;132:997\u20131000.e1\u20134.","journal-title":"J Allergy Clin Immunol"},{"key":"901_CR17","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1086\/657308","volume":"51","author":"G Uzel","year":"2010","unstructured":"Uzel G, Orange JS, Poliak N, Marciano BE, Heller T, Holland SM. Complications of tumor necrosis factor-\u03b1 blockade in chronic granulomatous disease-related colitis. Clin Infect Dis. 2010;51:1429\u201334.","journal-title":"Clin Infect Dis"},{"key":"901_CR18","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.jaci.2011.04.028","volume":"128","author":"C Deffert","year":"2011","unstructured":"Deffert C, Olleros ML, Huiping Y, Herrmann FR, Zekry D, Garcia I, et al. TNF-\u03b1 blockade in chronic granulomatous disease-induced hyperinflammation: patient analysis and murine model. J Allergy Clin Immunol. 2011;128:675\u20137.","journal-title":"J Allergy Clin Immunol"},{"key":"901_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11894-016-0491-3","volume":"18","author":"M Uzzan","year":"2016","unstructured":"Uzzan M, Ko HM, Mehandru S, Cunningham-Rundles C. Gastrointestinal disorders associated with common variable immune deficiency (CVID) and chronic granulomatous disease (CGD). Curr Gastroenterol Rep. 2016;18:17.","journal-title":"Curr Gastroenterol Rep"},{"key":"901_CR20","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1093\/jpids\/piy014","volume":"7","author":"SE Henrickson","year":"2018","unstructured":"Henrickson SE, Jongco AM, Thomsen KF, Garabedian EK, Thomsen IP. Noninfectious manifestations and complications of chronic granulomatous disease. J Pediatr Infect Dis Soc. 2018;7:S18\u201324.","journal-title":"J Pediatr Infect Dis Soc"},{"key":"901_CR21","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/S1542-3565(04)00292-7","volume":"2","author":"JS Huang","year":"2004","unstructured":"Huang JS, Noack D, Rae J, Ellis BA, Newbury R, Pong AL, et al. Chronic granulomatous disease caused by a deficiency in p47(phox) mimicking Crohn\u2019s disease. Clin Gastroenterol Hepatol. 2004;2:690\u20135.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"901_CR22","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.jaci.2005.01.016","volume":"115","author":"J Wang","year":"2005","unstructured":"Wang J, Mayer L, Cunningham-Rundles C. Use of GM-CSF in the treatment of colitis associated with chronic granulomatous disease. J Allergy Clin Immunol. 2005;115:1092\u20134.","journal-title":"J Allergy Clin Immunol"},{"key":"901_CR23","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.1182\/blood-2009-07-231498","volume":"114","author":"JD Matute","year":"2009","unstructured":"Matute JD, Arias AA, Wright NAM, Wrobel I, Waterhouse CCM, Li XJ, et al. A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity. Blood. 2009;114:3309\u201315.","journal-title":"Blood"},{"key":"901_CR24","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1365-2141.2009.07614.x","volume":"145","author":"E Soncini","year":"2009","unstructured":"Soncini E, Slatter MA, Jones LBKR, Hughes S, Hodges S, Flood TJ, et al. Unrelated donor and HLA-identical sibling haematopoietic stem cell transplantation cure chronic granulomatous disease with good long-term outcome and growth. Br J Haematol. 2009;145:73\u201383.","journal-title":"Br J Haematol"},{"key":"901_CR25","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.jaci.2008.07.050","volume":"122","author":"SS De Ravin","year":"2008","unstructured":"De Ravin SS, Naumann N, Cowen EW, et al. Chronic granulomatous disease as a risk factor for autoimmune disease. J Allergy Clin Immunol. 2008;122:1097\u2013103.","journal-title":"J Allergy Clin Immunol"},{"key":"901_CR26","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.3109\/00365521.2010.492529","volume":"45","author":"A Tommasini","year":"2010","unstructured":"Tommasini A, Pirrone A, Palla G, Taddio A, Martelossi S, Crovella S, et al. The universe of immune deficiencies in Crohn\u2019s disease: a new viewpoint for an old disease? Scand J Gastroenterol. 2010;45:1141\u20139.","journal-title":"Scand J Gastroenterol"},{"key":"901_CR27","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.jaci.2010.01.035","volume":"125","author":"F Freudenberg","year":"2010","unstructured":"Freudenberg F, Wintergerst U, Roesen-Wolff A, et al. Therapeutic strategy in p47-phox deficient chronic granulomatous disease presenting as inflammatory bowel disease. J Allergy Clin Immunol. 2010;125:943\u2013946.e1.","journal-title":"J Allergy Clin Immunol"},{"key":"901_CR28","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","volume":"295","author":"T Bongartz","year":"2006","unstructured":"Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA. 2006;295:2275\u201385.","journal-title":"JAMA"},{"key":"901_CR29","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2147\/DHPS.S28801","volume":"5","author":"T Ali","year":"2013","unstructured":"Ali T, Kaitha S, Mahmood S, Ftesi A, Stone J, Bronze MS. Clinical use of anti-TNF therapy and increased risk of infections. Drug Healthc Patient Saf. 2013;5:79\u201399.","journal-title":"Drug Healthc Patient Saf"},{"key":"901_CR30","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.autrev.2013.06.002","volume":"13","author":"S Ben-Horin","year":"2014","unstructured":"Ben-Horin S, Kopylov U, Chowers Y. Optimizing anti-TNF treatments in inflammatory bowel disease. Autoimmun Rev. 2014;13:24\u201330.","journal-title":"Autoimmun Rev"},{"issue":"Suppl 1","key":"901_CR31","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1007\/s10875-007-9160-5","volume":"28","author":"SD Rosenzweig","year":"2008","unstructured":"Rosenzweig SD. Inflammatory manifestations in chronic granulomatous disease (CGD). J Clin Immunol. 2008;28(Suppl 1):S67\u201372.","journal-title":"J Clin Immunol"},{"issue":"Suppl 1","key":"901_CR32","first-page":"S32","volume":"69","author":"D Goldblatt","year":"2014","unstructured":"Goldblatt D. Recent advances in chronic granulomatous disease. J Inf Secur. 2014;69(Suppl 1):S32\u20135.","journal-title":"J Inf Secur"},{"key":"901_CR33","doi-asserted-by":"publisher","first-page":"252460","DOI":"10.1155\/2012\/252460","volume":"2012","author":"N Rieber","year":"2012","unstructured":"Rieber N, Hector A, Kuijpers T, Roos D, Hartl D. Current concepts of hyperinflammation in chronic granulomatous disease. Clin Dev Immunol. 2012;2012:252460.","journal-title":"Clin Dev Immunol"},{"key":"901_CR34","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.jaci.2011.03.028","volume":"127","author":"EM Kang","year":"2011","unstructured":"Kang EM, Marciano BE, DeRavin S, Zarember KA, Holland SM, Malech HL. Chronic granulomatous disease: overview and hematopoietic stem cell transplantation. J Allergy Clin Immunol. 2011;127:1319\u201326 quiz 1327\u20131328.","journal-title":"J Allergy Clin Immunol"},{"key":"901_CR35","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/S0140-6736(13)62069-3","volume":"383","author":"T G\u00fcng\u00f6r","year":"2014","unstructured":"G\u00fcng\u00f6r T, Teira P, Slatter M, Stussi G, Stepensky P, Moshous D, et al. Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study. Lancet. 2014;383:436\u201348.","journal-title":"Lancet"},{"key":"901_CR36","doi-asserted-by":"publisher","first-page":"4367","DOI":"10.1182\/blood-2010-10-312082","volume":"117","author":"MA Slatter","year":"2011","unstructured":"Slatter MA, Rao K, Amrolia P, Flood T, Abinun M, Hambleton S, et al. Treosulfan-based conditioning regimens for hematopoietic stem cell transplantation in children with primary immunodeficiency: United Kingdom experience. Blood. 2011;117:4367\u201375.","journal-title":"Blood"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-020-00901-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-020-00901-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-020-00901-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,30]],"date-time":"2021-01-30T03:17:10Z","timestamp":1611976630000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-020-00901-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,4]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["901"],"URL":"https:\/\/doi.org\/10.1007\/s10875-020-00901-8","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,4]]},"assertion":[{"value":"15 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}